Medicross Medicaments Limited - Company Profile

It is a chemicals public limited company based in New Delhi, Delhi, India, established in 2011.
2011 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Medicross Medicaments Limited

Medicross Medicaments Limited, a struck off public limited company, was established on 10 February 2011 in New Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232DL2011PLC213715. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Sunil Kumar Sharma (Director), Neeraj Deewan (Director), Bijender Kumar Jain (Director). It is based at 107-112, Aggarwal Plaza, F-Block Dda Shopping Complex, Vikas Puri, New Delhi, Delhi, 110018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2011PLC213715

  • Registration Number

    213715

  • Incorporation Date

    10 February 2011

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 15 Year, 22 Days
Company report

Medicross Medicaments Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medicross Medicaments Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medicross Medicaments Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Kumar Sharma Director 10 Feb 2011 Current
Neeraj Deewan Director 10 Feb 2011 Current
Bijender Kumar Jain Director 10 Feb 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medicross Medicaments.

Enhance accessibility to Medicross Medicaments's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medicross Medicaments revenue growth over time
Medicross Medicaments profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medicross Medicaments?

Unlock access to Medicross Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medicross Medicaments?

Unlock and access historical data on people associated with Medicross Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medicross Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicross Medicaments's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medicross Medicaments
Recent Activity within the Organization
  • Director Appointment

    Progress on Sunil Kumar Sharma was appointed as a Director was appointed as a Director on 10 Feb 2011 & has been associated with this company since 15 years 22 days . was documented.

  • Director Appointment

    Neeraj Deewan was appointed as a Director was appointed as a Director on 10 Feb 2011 & has been associated with this company since 15 years 22 days . was recorded as a recent event.

  • Director Appointment

    Progress on Bijender Kumar Jain was appointed as a Director was appointed as a Director on 10 Feb 2011 & has been associated with this company since 15 years 22 days . was documented.

  • Company Incorporation

    Progress on Medicross Medicaments Limited was registered on 10 Feb 2011 with Roc Delhi & aged 15 years 22 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medicross Medicaments Limited?

The CIN of Medicross Medicaments Limited is U24232DL2011PLC213715.

Where is Medicross Medicaments Limited headquartered?

Medicross Medicaments Limited is headquartered at 107-112, Aggarwal Plaza, F-Block Dda Shopping Complex, Vikas Puri, New Delhi, Delhi, 110018.

When was Medicross Medicaments Limited incorporated?

Medicross Medicaments Limited was incorporated on 10 February 2011.

Who are the current directors of Medicross Medicaments Limited?

The current directors of Medicross Medicaments Limited are

What is the primary industry of Medicross Medicaments Limited?

The primary industry of Medicross Medicaments Limited is Chemicals.

Is Medicross Medicaments Limited a listed company?

Medicross Medicaments Limited is unlisted.

What is the capital structure of Medicross Medicaments Limited?

The authorized capital of Medicross Medicaments Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available